ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2026 ANS Winter Conference & Expo
November 15–18, 2026
Phoenix, AZ|Arizona Grand Resort & Spa
Latest Magazine Issues
Sep 2026
Jan 2026
2026
Latest Journal Issues
Nuclear Science and Engineering
October 2026
Nuclear Technology
Fusion Science and Technology
Latest News
Westinghouse, Nordion, and PSEG team up to produce Co‑60 in the United States
This past January, Westinghouse Electric Company, Nordion, and PSEG Nuclear formalized agreements to implement newly developed cobalt-60 production technology at Units 1 and 2 of PSEG’s Salem nuclear power plant in New Jersey, with the Co-60 to be supplied to Nordion. Through an ongoing joint initiative, the companies aim to harness U.S. pressurized water reactors to produce a key medical isotope and build the first commercial-scale Co-60 production platform in the United States.
James A. Davis
Nuclear Science and Engineering | Volume 25 | Number 2 | June 1966 | Pages 189-197
Technical Paper | doi.org/10.13182/NSE66-A17736
Articles are hosted by Taylor and Francis Online.
Approximate vacuum boundary conditions for a PN approximation are obtained by variational methods. Two stationary principles are proposed, one having what we shall call “odd” Marshak conditions as its natural boundary conditions, and the other having “even” Marshak conditions as its natural boundary conditions. The principles are valid for arbitrary geometry. The odd Marshak conditions are seen to be suitable for an odd-order PN approximation and the even Marshak conditions for an even-order PN approximation. The odd Marshak conditions are precisely the conditions obtained by Vladimirov from an extremum principle in which certain restrictions are imposed on the source and scattering. The present treatment contains no such restrictions.